Preclinical and clinical activity of DZD1516, a full blood–brain barrier-penetrant, highly selective HER2 inhibitor

被引：0
作者：
Jian Zhang
Nicholas P. McAndrew
Xiaojia Wang
Yiqun Du
Brian DiCarlo
Mei Wang
Kan Chen
Wenlei Yu
Xichun Hu
机构：
[1] Fudan University Shanghai Cancer Center,Phase I Clinical Trial Center
[2] Fudan University,Department of Oncology, Shanghai Medical College
[3] UCLA David Geffen School of Medicine,Division of Hematology/Oncology
[4] Zhejiang Cancer Hospital,Department of Medical Oncology
[5] Dizal Pharmaceutical,undefined
[6] Fudan University Shanghai Cancer Center,undefined
来源：
Breast Cancer Research | / 25卷
关键词：
HER2; Tyrosine kinase inhibitor; Blood–brain barrier; Breast cancer; Central nervous system metastases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 124 条
[51]  
Jahanzeb M(undefined)undefined undefined undefined undefined-undefined
[52]  
Brufsky A(undefined)undefined undefined undefined undefined-undefined
[53]  
Kuksis M(undefined)undefined undefined undefined undefined-undefined
[54]  
Gao Y(undefined)undefined undefined undefined undefined-undefined
[55]  
Tran W(undefined)undefined undefined undefined undefined-undefined
[56]  
Hoey C(undefined)undefined undefined undefined undefined-undefined
[57]  
Kiss A(undefined)undefined undefined undefined undefined-undefined
[58]  
Komorowski AS(undefined)undefined undefined undefined undefined-undefined
[59]  
Lin NU(undefined)undefined undefined undefined undefined-undefined
[60]  
Lin NU(undefined)undefined undefined undefined undefined-undefined
12345678910